some improvements on the catalytic process for Cr-mediated
coupling reactions. In particular, it has been often observed
that, with low catalyst-loading, asymmetric catalytic cou-
plings smoothly progress only to a certain degree but not to
completion. Not surprisingly, it was found that this was due
to the formation of TMS-enol ethers of aldehydes. Thus, we
were interested in developing a new catalytic cycle for the
Cr-mediated couplings without use of TMS-Cl or an equiv-
alent reagent. Apparently, formation of a strong O-Cr(III)
bond is a driving force for addition of an organochromium
nucleophile to an aldehyde. Therefore, to establish a catalytic
cycle for the Cr-based reagent, a special means is required
to cleave the resultant strong O-Cr(III) bond. We were
curious about the possibility of transferring the alkoxyl group
to a second metal. Provided that the second metal has a
higher oxophilicity but a lower halophilicity than chromium,
this proposed step should be thermodynamically feasible
(IfIII in panel B, Scheme 1). Extrapolating the oxophilicity
and halophilicity estimated through combustion of a solid
metal propellant,6 we speculated that Be, Al, Zr, and Mg
might meet this condition. Consistent with this speculation,
we found that zirconocene indeed smoothly exchanges its
chloride ligand(s) with an alkoxy group(s),7,8 suggesting that
zirconocene might fulfill our needs both thermodynamically
and kinetically.
almost complete conversion, but with a lower efficiency
(57% yield). Overall, this chemical transformation is de-
scribed by eq 1 and, upon aqueous workup, unprotected
secondary alcohols are obtained.
It was equally exciting to find that the catalytic Ni/Cr-
mediated coupling proceeded in the presence of the chiral
sulfonamide 8a (Figure 1), thereby demonstrating the pos-
Figure 1. Chiral ligands for Ni/Cr-mediated couplings.
With these considerations, we tested a catalytic Ni/Cr-
mediated coupling of dihydrocinnamaldehyde (1, 1.0 equiv)
with 2-iodo-1-hexene (2a, 2.0 equiv)9 using CrCl2 (20 mol
%), NiCl2(dppp) (2 mol %), Cp2ZrCl2 (1.0 equiv), Mn (2.0
equiv), and LiCl (2.0 equiv) at room-temperature overnight
and were delighted to find that the coupling reaction did
proceed smoothly to furnish the expected allylic alcohol 3a
in 71% yield. It is noteworthy that, even with 0.5 equiv of
Cp2ZrCl2 against aldehyde 1, this catalytic process led to
sibility of extending this catalytic cycle to a catalytic asym-
metric process (vide infra). Encouraged with these results,
we then optimized the coupling conditions (Scheme 2).
Several comments are in order. First, with small modifica-
tions, this catalytic process is effective for all three subgroups
of Cr-mediated couplings,4,10,11 i.e., (1) Ni/Cr-mediated alken-
ylation, (2) Co/Cr- and Fe/Cr-mediated 2-haloallylation and
alkylation, and (3) Cr-mediated allylation. Second, the cata-
lyst loading can be lowered to 5 mol % without significant
losses in chemical yields. Importantly, even under these con-
ditions, aldehydes were completely consumed. Third, among
the tested zirconium salts,12 Cp2ZrCl2 was found to be best
by far. Fourth, among the tested reducing agents,13 manga-
nese metal (powder) was found to give the best result. Last,
we would suggest the catalytic cycle depicted in Scheme 3.
Sulfonamide ligands have been shown to effect an asym-
metric induction for the Cr-mediated couplings under both
stoichiometric and catalytic conditions.4 A similar trend is
observed for the new catalytic process. Good asymmetric
inductions were observed for the Ni/Cr-mediated alkenylation
(86% ee for 1 + 2a with 8b14), Co/Cr-mediated 2-haloal-
lylation (90% ee for 1 + 4a with 8c10) and propargylation
(82% ee for 1 + 4c with 8c10), and Cr-mediated allylation
(>90% ee for 1 + 6b with 8c10). However, a ligand
optimization is still needed for the Ni/Cr-mediated alkeny-
(2) (a) Fu¨rstner, A.; Shi, N. J. Am. Chem. Soc. 1996, 118, 2533-2534.
(b) Fu¨rstner, A.; Shi, N. J. Am. Chem. Soc. 1996, 118, 12349-12357.
(3) (a) Grigg, R.; Putnikovic, B.; Urcch, C. J. Tetrahedron Lett. 1997,
38, 6307-6308. (b) Kuroboshi, M.; Tanaka, M.; Kishimoto, S.; Goto, K.;
Tanaka, H.; Torii, S. Tetrahedron Lett. 1999, 40, 2785-2788. (c) Kuroboshi,
M.; Tanaka, M.; Kishimoto, S.; Tanaka, H.; Torii, S. Synlett. 1999, 69-
70. (d) Durandetti, M.; Nedelec, J.-Y.; Perichon, J. Org. Lett. 2001, 3, 2073-
2076.
(4) (a) Wan, Z.-K.; Choi, H.-W.; Kang, F.-A.; Nakajima, K.; Demeke,
D.; Kishi, Y. Org. Lett. 2002, 4, 4431-4434. (b) Choi, H.-W.; Nakajima,
K.; Demeke, D.; Kang, F.-A.; Jun, H.-S.; Wan, Z.-K.; Kishi, Y. Org. Lett.
2002, 4, 4435-4438. (c) Choi, H.; Demeke, D.; Kang, F.-A.; Kishi, Y.;
Nakajima, K.; Nowak, P.; Wan, Z.-K.; Xie, C. Pure Appl. Chem. 2003, 75,
1-17.
(5) (a) Bandini, M.; Cozzi, P. G.; Melchiorre, P.; Umani-Ronchi, A.
Angew Chem., Int. Ed. 1999, 38, 3357-3359. Bandini, M.; Cozzi, P. G.;
Umani-Ronchi, A. Chem. Commun. 2002, 919-927 and references therein.
Jacobsen’s Cr complex was used for these studies. (b) Lombardo, M.;
Licciulli, S.; Morganti, S.; Trombini, C. Chem. Commun. 2003, 1762-
1763. Jacobsen’s Cr complex was used for these studies. (c) Berkessel, A.;
Menche, D.; Sklorz, C. A.; Schroder, M.; Paterson, I. Angew Chem., Int.
Ed. 2003, 42, 1032-1035. Paterson, I.; Bergmann, H.; Menche, D.;
Berkessel, A. Org. Lett. 2004, 6, 1293-1295. (d) Inoue, M.; Suzuki, T.;
Nakada, M. J. Am. Chem. Soc. 2003, 125, 1140-1141. Inoue, M.; Nakada,
M. Org. Lett. 2004, 2977-2980.
(10) Kurosu, M.; Lin, M.-H.; Kishi, Y. J. Am. Chem. Soc. 2004, 126,
12248-12249.
(11) CrCl3 and CrBr3 are as effective as CrCl2 and CrBr2. In consideration
of the commercial availability and cost, anhydrous CrCl2 and CrBr3 have
been used for this study.
(12) These included Zr(OPr-i)4, Zr(acac)4, and ZrCl4.
(13) Among metals tested, Zn was effective, but the reaction with Zn
was not as clean as with Mn.
(6) Kuehl, D. K. U.S. Patent 3133841 19640519, 1964.
(7) (a) Gray, D. R.; Brubaker, C. H., Jr. Inorg. Chem. 1971, 10, 2143-
2146. (b) Femec, D. A.; Silver, M. E.; Fay, R. C. Inorg. Chem. 1989, 28,
2789-2796 and references therein.
(8) On treatment with 2-PrOH (1.0 equiv) and TEA (1.0 equiv) in
CD3CN, a clean and complete ligand exchange was observed between the
Cl of Cp2ZrCl2 and 2-PrOH (NMR).
(9) Corresponding triflate was also a good substrate.
(14) Shi, B.; Cui, S.; Kishi, Y. Unpublished work.
5032
Org. Lett., Vol. 6, No. 26, 2004